Radiation oncology during COVID-19: Strategies to avoid compromised care
- PMID: 32894820
- DOI: 10.1111/ajco.13456
Radiation oncology during COVID-19: Strategies to avoid compromised care
Abstract
The COVID-19 pandemic will present a range of challenges to radiation oncology departments. Early data suggest that cancer patients carry a higher than average, but still low absolute risk of hospitalization from COVID-19. The risk of severe events for those who are hospitalized however, is high. Resources for usual cancer care will likely be limited. Decisions to alter, delay or omit treatment during this period should consider both the risk of the cancer and of COVID-19 to the patient, as well as resource constraints. There is a need for departments to adapt with goals of maintaining an uninterrupted, high quality service and of minimizing compromise to oncologic care.
Keywords: COVID-19; SARS-CoV-2; cancer; radiation oncology; radiotherapy.
© 2020 John Wiley & Sons Australia, Ltd.
References
REFERENCES
-
- Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337.
-
- Yu J, Ouyang W, Chua MLK, Xie C, SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. medRxiv. 2020. https://doi.org/10.1101/2020.02.22.20025320
-
- Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901.
-
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
-
- W-j Guan, W-h Liang, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis. Eur Respir J. 2020:2000547. https://doi.org/10.1183/13993003.00547-2020.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous